Elliott-Lewis et al v. Abbott Laboratories, Inc.

  1. November 06, 2019

    Abbott Scores Win In Ex-Researcher's Retaliation Suit

    A former Abbott Laboratories medical manager lost a five-year legal battle in which she accused her former employer of retaliation after she refused to go along with a supposedly illegal marketing scheme when a federal judge ruled Wednesday that her dismissal is not tied to any protected activity.

  2. May 09, 2019

    Ex-Abbott Researcher Can't Duplicate Termination Claims

    A former Abbott Laboratories Inc. researcher who has doggedly pursued claims against her former employer for more than four years cannot file a new suit that would in effect duplicate one she is already pursuing, a Massachusetts federal judge ruled Thursday.

  3. October 02, 2018

    Ex-Abbott Researcher Says 'Erroneous' Law Sank FCA Claims

    A former medical science liaison for Abbott Laboratories Inc. refuses to accept that her False Claims Act allegations against Abbott died on anything other than "erroneous" case law, asking a Massachusetts federal judge on Tuesday to pause her case indefinitely until new precedent supports her views.

  4. March 15, 2018

    Abbott Says Ex-Employee Should Pay For Dismissed FCA Suit

    Abbott Laboratories Inc. on Thursday asked a Massachusetts federal judge to send its legal bill to an ex-employee who brought back a previously dismissed False Claims Act lawsuit with claims the pharmaceutical company says were already thrown out.

  5. April 06, 2015

    Abbott Says FCA Suit Over Preapproval Promotion Fails

    Abbott Laboratories Inc. on Friday urged a Massachusetts federal judge to dismiss a False Claims Act and retaliation suit, saying it's impossible a false claim was submitted for its coronary artery disease device because it's not yet commercially available.

  6. December 16, 2014

    Ex-Employee Accuses Abbott Of Retaliation In FCA Suit

    A False Claims Act suit unsealed in Massachusetts federal court on Monday accuses Abbott Laboratories Inc. of retaliating against a former medical manager after her refusal to participate in a supposedly illegal marketing scheme that affected Medicare and Medicaid payments.